83.2%
NSCLCmetastatic melanomaStage IV non-small cell lung cancerStage IV melanomaSARS-COV-2 mRNA vaccinesMD Anderson Cancer Center
…ociated with a near doubling of OS among patients with Stage IV NSCLC (555 days vs 1120 days, adj HR 0.5, 95% CI 0.4-0.7) and Stage I…